These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6942761)

  • 1. Quantum chemical studies on molecular determinants for drug action.
    Weinstein H; Osman R; Topiol S; Green JP
    Ann N Y Acad Sci; 1981; 367():434-51. PubMed ID: 6942761
    [No Abstract]   [Full Text] [Related]  

  • 2. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 3. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL; Lien EJ; Shih JC
    NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
    [No Abstract]   [Full Text] [Related]  

  • 4. Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Eur J Pharmacol; 1977 Oct; 45(4):341-8. PubMed ID: 923645
    [No Abstract]   [Full Text] [Related]  

  • 5. Is 2-bromo-D-lysergic acid diethylamide (BOL) an allosteric antagonist of serotonergic receptors in rabbit atria?
    Xu Z; Purdy RE
    Proc West Pharmacol Soc; 1988; 31():181-3. PubMed ID: 2905465
    [No Abstract]   [Full Text] [Related]  

  • 6. LSD and 2-bromo-LSD: comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala.
    Aghajanian GK
    Neuropharmacology; 1976 Sep; 15(9):521-8. PubMed ID: 10535
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular modeling of N-isopropyl lisergamides analogous to LSD using molecular mechanics and quantum mechanical calculations].
    Cordero de Troconis MI; Pfaff R; Nichols D
    Acta Cient Venez; 1997; 48(2):85-90. PubMed ID: 9567327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The computational design of test compounds with potentially specific biological activity: histamine-H2 agonists derived from 5-HT/H2 antagonists.
    Topiol S; Sabio M
    J Comput Aided Mol Des; 1991 Jun; 5(3):263-72. PubMed ID: 1919620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin receptors in the brain.
    Haigler HJ; Aghajanian GK
    Fed Proc; 1977 Jul; 36(8):2159-64. PubMed ID: 326580
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantum chemical studies on drug actions. IV. Correlation of substituent structures and anti-serotonin activity in lysergamide series.
    Sankar DV; Kumbar M
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):259-74. PubMed ID: 4818373
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

  • 15. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum chemical approach to the relationship between molecular structure and serotonin receptor binding affinity.
    Gómez-Jeria JS; Morales-Lagos DR
    J Pharm Sci; 1984 Dec; 73(12):1725-8. PubMed ID: 6527244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LSD-25, tranylcypromine and the serotoninergic system of the rat brain].
    Torre M; Bogetto F; Torre E
    Boll Soc Ital Biol Sper; 1976 Nov; 52(21):1842-5. PubMed ID: 1026258
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of hydrophobicity in the antiserotonin activity of LSD analogs.
    Dunn WJ; Bederka JP
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):275-85. PubMed ID: 4818374
    [No Abstract]   [Full Text] [Related]  

  • 19. The characterization of 5-HT receptors. Introduction.
    Bradley PB
    Neuropharmacology; 1984 Dec; 23(12B):1465-6. PubMed ID: 6527746
    [No Abstract]   [Full Text] [Related]  

  • 20. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.